Immune-related genes and gene sets for predicting the response to anti-programmed death 1 therapy in patients with primary or metastatic non-small cell lung cancer

Although antibodies targeting the immune checkpoint protein programmed death-1 (PD-1) exert therapeutic effects in patients with primary or metastatic non-small cell lung cancer (NSCLC), the majority of patients exhibit partial or complete resistance to anti-PD1 treatment. Thus, the aim of the prese...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Bolin, Yang, Min, Li, Kang, Li, Jia, Xu, Li, Xu, Fang, Xu, Yan, Ren, Dandan, Zhang, Jiao, Liu, Liyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161458/
https://www.ncbi.nlm.nih.gov/pubmed/34084219
http://dx.doi.org/10.3892/ol.2021.12801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161458/
https://www.ncbi.nlm.nih.gov/pubmed/34084219
http://dx.doi.org/10.3892/ol.2021.12801

Ejemplares similares